TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients.
The House Ways & Means Committee on May 21 unanimously advanced the Provider Reimbursement Stability Act of 2026, which is endorsed by multiple radiology societies.
The U.S. Department of Justice says its investigation into the scheme to defraud Amtrak’s employee health plan resulted in 19 prosecutions, all resulting in guilty pleas. For her role in over $2.2M of fraudulent billing, physical therapist Taejin Kim will serve a year in prison.
In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections.
Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.
Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients.
